Melissa Terpstra1, Ian Cheong1, Tianmeng Lyu2, Dinesh K Deelchand1, Uzay E Emir1, Petr Bednařík1,3,4, Lynn E Eberly2, Gülin Öz5. 1. Center for Magnetic Resonance Research, Department of Radiology, University of Minnesota, Minneapolis, Minnesota, USA. 2. Division of Biostatistics, School of Public Health, University of Minnesota, Minneapolis, Minnesota, USA. 3. Division of Endocrinology and Diabetes, Department of Medicine, University of Minnesota, Minneapolis, Minnesota, USA. 4. Multimodal and Functional Neuroimaging Research Group, Central European Institute of Technology, Masaryk University, Brno, Czech Republic. 5. Center for Magnetic Resonance Research, Department of Radiology, University of Minnesota, Minneapolis, Minnesota, USA. gulin@cmrr.umn.edu.
Abstract
PURPOSE: To determine the test-retest reproducibility of neurochemical concentrations obtained with a highly optimized, short-echo, single-voxel proton MR spectroscopy (MRS) pulse sequence at 3T and 7T using state-of-the-art hardware. METHODS: A semi-LASER sequence (echo time = 26-28 ms) was used to acquire spectra from the posterior cingulate and cerebellum at 3T and 7T from six healthy volunteers who were scanned four times weekly on both scanners. Spectra were quantified with LCModel. RESULTS: More neurochemicals were quantified with mean Cramér-Rao lower bounds (CRLBs) ≤20% at 7T than at 3T despite comparable frequency-domain signal-to-noise ratio. Whereas CRLBs were lower at 7T (P < 0.05), between-session coefficients of variance (CVs) were comparable at the two fields with 64 transients. Five metabolites were quantified with between-session CVs ≤5% at both fields. Analysis of subspectra showed that a minimum achievable CV was reached with a lower number of transients at 7T for multiple metabolites and that between-session CVs were lower at 7T than at 3T with fewer than 64 transients. CONCLUSION: State-of-the-art MRS methodology allows excellent reproducibility for many metabolites with 5-min data averaging on clinical 3T hardware. Sensitivity and resolution advantages at 7T are important for weakly represented metabolites, short acquisitions, and small volumes of interest. Magn Reson Med 76:1083-1091, 2016.
PURPOSE: To determine the test-retest reproducibility of neurochemical concentrations obtained with a highly optimized, short-echo, single-voxel proton MR spectroscopy (MRS) pulse sequence at 3T and 7T using state-of-the-art hardware. METHODS: A semi-LASER sequence (echo time = 26-28 ms) was used to acquire spectra from the posterior cingulate and cerebellum at 3T and 7T from six healthy volunteers who were scanned four times weekly on both scanners. Spectra were quantified with LCModel. RESULTS: More neurochemicals were quantified with mean Cramér-Rao lower bounds (CRLBs) ≤20% at 7T than at 3T despite comparable frequency-domain signal-to-noise ratio. Whereas CRLBs were lower at 7T (P < 0.05), between-session coefficients of variance (CVs) were comparable at the two fields with 64 transients. Five metabolites were quantified with between-session CVs ≤5% at both fields. Analysis of subspectra showed that a minimum achievable CV was reached with a lower number of transients at 7T for multiple metabolites and that between-session CVs were lower at 7T than at 3T with fewer than 64 transients. CONCLUSION: State-of-the-art MRS methodology allows excellent reproducibility for many metabolites with 5-min data averaging on clinical 3T hardware. Sensitivity and resolution advantages at 7T are important for weakly represented metabolites, short acquisitions, and small volumes of interest. Magn Reson Med 76:1083-1091, 2016.
Authors: Petr Bednařík; Amir Moheet; Dinesh K Deelchand; Uzay E Emir; Lynn E Eberly; Martin Bareš; Elizabeth R Seaquist; Gülin Öz Journal: NMR Biomed Date: 2015-04-22 Impact factor: 4.044
Authors: Frank Träber; Wolfgang Block; Nikolaus Freymann; Okan Gür; Thomas Kucinski; Thilo Hammen; Gabriele Ende; Ulrich Pilatus; Harald Hampel; Hans H Schild; Reinhard Heun; Frank Jessen Journal: Eur Radiol Date: 2006-01-17 Impact factor: 5.315
Authors: Ivan I Kirov; Ilena C George; Nikhil Jayawickrama; James S Babb; Nissa N Perry; Oded Gonen Journal: Magn Reson Med Date: 2011-06-07 Impact factor: 4.668
Authors: Małgorzata Marjańska; Edward J Auerbach; Romain Valabrègue; Pierre-François Van de Moortele; Gregor Adriany; Michael Garwood Journal: NMR Biomed Date: 2011-07-27 Impact factor: 4.044
Authors: Hetty Prinsen; Robin A de Graaf; Graeme F Mason; Daniel Pelletier; Christoph Juchem Journal: J Magn Reson Imaging Date: 2016-06-28 Impact factor: 4.813
Authors: Young Woo Park; Dinesh K Deelchand; James M Joers; Brian Hanna; Adam Berrington; Joseph S Gillen; Kejal Kantarci; Brian J Soher; Peter B Barker; HyunWook Park; Gülin Öz; Christophe Lenglet Journal: Magn Reson Med Date: 2018-04-06 Impact factor: 4.668
Authors: S Andrea Wijtenburg; Jamie Near; Stephanie A Korenic; Frank E Gaston; Hongji Chen; Mark Mikkelsen; Shuo Chen; Peter Kochunov; L Elliot Hong; Laura M Rowland Journal: J Magn Reson Imaging Date: 2018-04-16 Impact factor: 4.813
Authors: Maria do Carmo Costa; Maria Radzwion; Hayley S McLoughlin; Naila S Ashraf; Svetlana Fischer; Vikram G Shakkottai; Patrícia Maciel; Henry L Paulson; Gülin Öz Journal: Mov Disord Date: 2020-07-04 Impact factor: 10.338
Authors: Burcu Zeydan; Dinesh K Deelchand; Nirubol Tosakulwong; Timothy G Lesnick; Orhun H Kantarci; Mary M Machulda; David S Knopman; Val J Lowe; Clifford R Jack; Ronald C Petersen; Gülin Öz; Kejal Kantarci Journal: J Neuroimaging Date: 2017-06-29 Impact factor: 2.486
Authors: Gülin Öz; Dinesh K Deelchand; Jannie P Wijnen; Vladimír Mlynárik; Lijing Xin; Ralf Mekle; Ralph Noeske; Tom W J Scheenen; Ivan Tkáč Journal: NMR Biomed Date: 2020-01-10 Impact factor: 4.044
Authors: S Andrea Wijtenburg; Laura M Rowland; Georg Oeltzschner; Peter B Barker; Clifford I Workman; Gwenn S Smith Journal: NMR Biomed Date: 2018-11-29 Impact factor: 4.044